Page last updated: 2024-08-25

chitosan and Cardiotoxicity

chitosan has been researched along with Cardiotoxicity in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's4 (80.00)2.80

Authors

AuthorsStudies
Chang, H; Jeon, S; Kim, K; Lee, S; Shim, MK; Yhee, JY; Yoon, HY1
Luo, X1
Abo Mansour, HE; Abo-Elmatty, DM; Badawy, NS; El-Batsh, MM; Mehanna, ET; Mesbah, NM2
Kazem, A; Nafee, N; Nasr, M; Saad, H1

Reviews

1 review(s) available for chitosan and Cardiotoxicity

ArticleYear
Nanobiotechnology-based strategies in alleviation of chemotherapy-mediated cardiotoxicity.
    Environmental research, 2023, 12-01, Volume: 238, Issue:Pt 2

    Topics: Antineoplastic Agents; Cardiotoxicity; Cardiovascular Diseases; Chitosan; Heart Diseases; Humans; Neoplasms; Pharmaceutical Preparations

2023

Other Studies

4 other study(ies) available for chitosan and Cardiotoxicity

ArticleYear
In vivo toxicity evaluation of tumor targeted glycol chitosan nanoparticles in healthy mice: repeated high-dose of glycol chitosan nanoparticles potentially induce cardiotoxicity.
    Journal of nanobiotechnology, 2023, Mar-09, Volume: 21, Issue:1

    Topics: Animals; Cardiotoxicity; Chitosan; Drug Delivery Systems; Mice; Nanoparticles; Neoplasms

2023
Effect of co-treatment with doxorubicin and verapamil loaded into chitosan nanoparticles on diethylnitrosamine-induced hepatocellular carcinoma in mice.
    Human & experimental toxicology, 2020, Volume: 39, Issue:11

    Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Calcium Channel Blockers; Carcinoma, Hepatocellular; Cardiotoxicity; Cell Survival; Chitosan; Diethylnitrosamine; Doxorubicin; Drug Combinations; Drug Delivery Systems; Hep G2 Cells; Humans; Liver; Liver Neoplasms; Male; Malondialdehyde; Mice; Myocardium; Nanoparticles; Proto-Oncogene Proteins c-bcl-2; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; Verapamil

2020
Ginger Extract Loaded into Chitosan Nanoparticles Enhances Cytotoxicity and Reduces Cardiotoxicity of Doxorubicin in Hepatocellular Carcinoma in Mice.
    Nutrition and cancer, 2021, Volume: 73, Issue:11-12

    Topics: Animals; Carcinoma, Hepatocellular; Cardiotoxicity; Chitosan; Doxorubicin; Liver Neoplasms; Male; Mice; Nanoparticles; Plant Extracts; Vascular Endothelial Growth Factor A; Zingiber officinale

2021
Improved antitumor activity and reduced cardiotoxicity of epirubicin using hepatocyte-targeted nanoparticles combined with tocotrienols against hepatocellular carcinoma in mice.
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2014, Volume: 88, Issue:1

    Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cardiotoxicity; Cell Survival; Chitosan; Disease Models, Animal; Drug Delivery Systems; Epirubicin; Glutathione; Heart; Hep G2 Cells; Hepatocytes; Humans; Lactic Acid; Lipid Peroxidation; Liver; Liver Neoplasms; Mice; Nanoparticles; Neovascularization, Pathologic; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Superoxide Dismutase; Tocotrienols; Tumor Suppressor Protein p53

2014